-
Penrith Panthers Face Backlash Over Decision to Disband Pantherettes Cheerleading Squad
-
USC Football Eliminated from College Playoff Hopes After Loss to Indiana
-
Make-A-Wish Announces 2026 Starblazer Award Honorees; Allied World Becomes First Corporate Founder
-
Dianna Russini Seeks Super Bowl Radio Row Credential Amid Media Return
-
Lee-Trump Golf Diplomacy Faces Diplomatic Dilemma Ahead of G20 Summit
-
South Africa's Universal Health Coverage Depends on Tackling Poverty and Inequality
-
Mavericks Defeat Jazz 112-100 Behind Washington’s 26 Points and Second-Half Surge
-
Chelsea Transfer News: Real Betis Star Jose Antonio Morante Rejects Move to Stamford Bridge
-
BingX: Major Announcement of Far-Reaching Significance
-
TikTok Security Chief Advises SMBs on Free Cybersecurity Protections
-
James Blunt Scores First Number One Album in 19 Years; Wife Sofia Wellesley Celebrates
-
Egypt Revokes Citizenship of Brothers Anas and Tarek Habib Over Unapproved Foreign Nationality
-
UCLA Stays Unbeaten With Ty Dieffenbach's Heroic Return Against Illinois
-
2027 Rivian R2 Performance vs. 2026 Jeep Recon Moab: EV Comparison Test
Roche says will invest $50 bn in US over next five years
Swiss pharmaceutical giant Roche on Tuesday announced plans to invest $50 billion in the United States over the next five years.
"These investments further strengthen Roche's already significant US footprint with 13 manufacturing and 15 R&D sites across the pharmaceutical and diagnostics divisions, and are expected to create more than 12,000 new jobs," a company statement said.
The firm already has plants in the United States, and said the move would help expand capacity at sites in Kentucky, Indiana, New Jersey, Oregon and California.
"Today’s announced investments underscore our long-standing commitment to research, development and manufacturing in the US," said Roche Group chief executive Thomas Schinecker.
"Our investments of $50 billion over the next five years will lay the foundation for our next era of innovation and growth, benefiting patients in the US and around the world."
C.Stoecklin--VB